Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R. Mathew(University of Freiburg), Francis Baumgartner(University of Freiburg), Lukas M. Braun(University of Freiburg), David O’Sullivan(Max Planck Institute of Immunobiology and Epigenetics), Simone Thomas(University Hospital Regensburg), Miguel Waterhouse(University of Freiburg), Tony Andreas Müller(University of Freiburg), Kathrin Hanke(University of Freiburg), Sanaz Taromi(University of Freiburg), Petya Apostolova(University of Freiburg), Anna Lena Illert(University of Freiburg), Wolfgang Melchinger(University of Freiburg), Sandra Duquesne(University of Freiburg), Annette Schmitt‐Graeff(University of Freiburg), Lena Oßwald(University of Freiburg), Kaili Yan(University of Freiburg), Arnim Weber(University of Freiburg), Sònia Tugues(University of Zurich), Sabine Spath(University of Zurich), Dietmar Pfeifer(University of Freiburg), Marie Follo(University of Freiburg), Rainer Claus(University of Freiburg), Michael Lübbert(University of Freiburg), Christoph Rummelt(University of Freiburg), Hartmut Bertz(University of Freiburg), Ralph Wäsch(University of Freiburg), Johanna Haag(University of Freiburg), Andrea Schmidts(University of Freiburg), Michael Schultheiß(University of Freiburg), Dominik Bettinger(University of Freiburg), Robert Thimme(University of Freiburg), Evelyn Ullrich(Goethe University Frankfurt), Yakup Tanriver(University of Freiburg), Giang Lam Vuong(Charité - Universitätsmedizin Berlin), Renate Arnold(Charité - Universitätsmedizin Berlin), Philipp Hemmati(Charité - Universitätsmedizin Berlin), Dominik Wolf(Innsbruck Medical University), Markus Ditschkowski(Essen University Hospital), Cordula A. Jilg(University of Freiburg), Konrad Wilhelm(University of Freiburg), Christian Leiber(University of Freiburg), Sabine Gerull(University Hospital of Basel), Jörg Halter(University Hospital of Basel), Claudia Lengerke(University Hospital of Basel), Thomas Pabst(University Hospital of Bern), Thomas Schroeder(Düsseldorf University Hospital), Guido Kobbe(Düsseldorf University Hospital), Wolf Rösler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Soroush Doostkam(University of Freiburg), Stephan Meckel(University of Freiburg), Kathleen Stabla(Philipps University of Marburg), Stephan Metzelder(Philipps University of Marburg), Sebastian Halbach(University of Freiburg), Tilman Brummer(University of Freiburg), Zehan Hu(University of Fribourg), Jörn Dengjel(University of Fribourg), Björn Hackanson(University Hospital Augsburg), Christoph Schmid(University Hospital Augsburg), Udo Holtick(University Hospital Cologne), Christof Scheid(University Hospital Cologne), Alexandros Spyridonidis(University of Patras), Friedrich Stölzel(University Hospital Carl Gustav Carus), Rainer Ordemann(University Hospital Carl Gustav Carus), Lutz Müller(University Hospital in Halle), Flore Sicre-de-Fontbrune(Inserm), Gabriele Ihorst(University of Freiburg), Jürgen Kuball(University Medical Center Utrecht), Jan E. Ehlert, Daniel Feger, Eva-Maria Wagner(Johannes Gutenberg University Mainz), Jean‐Yves Cahn(Centre Hospitalier Universitaire de Grenoble), Jacqueline Schnell(University Hospital Ulm), Florian Kuchenbauer(University Hospital Ulm), Donald Bunjes(University Hospital Ulm), Ronjon Chakraverty(The Royal Free Hospital), Simon Richardson(The Royal Free Hospital), Saar Gill(Hospital of the University of Pennsylvania), Nicolaus Kröger(Universität Hamburg), Francis Ayuk(Universität Hamburg), Luca Vago(Vita-Salute San Raffaele University), Fabio Ciceri(Vita-Salute San Raffaele University), Antonia Müller(University Hospital of Zurich), Takeshi Kondo(Hokkaido University), Takanori Teshima(Hokkaido University), Susan Klaeger(German Cancer Research Center), Bernhard Küster(German Cancer Research Center), Dennis Dong Hwan Kim(University of Toronto), Daniel J. Weisdorf(University of Minnesota), Walter J. F. M. van der Velden(Radboud University Nijmegen), Daniela Dörfel(Universitätsklinikum Tübingen), Wolfgang Bethge(Universitätsklinikum Tübingen), Inken Hilgendorf(Jena University Hospital), Andreas Hochhaus(Jena University Hospital), Geoffroy Andrieux(University of Freiburg), Melanie Börries(University of Freiburg), Hauke Busch(University of Freiburg), John Magenau(University of Michigan), Pavan Reddy(University of Michigan), Myriam Labopin(Sorbonne Université), Joseph H. Antin(Harvard University), Andrea Henden(QIMR Berghofer Medical Research Institute), Geoffrey R. Hill(QIMR Berghofer Medical Research Institute), Glen Kennedy(Royal Brisbane and Women's Hospital), Merav Bar(University of Washington), Anita Sarma(King's College Hospital NHS Foundation Trust), Donal P. McLornan(King's College Hospital NHS Foundation Trust), Ghulam Mufti(King's College Hospital NHS Foundation Trust), Betül Oran(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Omid Shah(Stanford University), Robert S. Negrin(Stanford University), Arnon Nagler(Sheba Medical Center), Marco Prinz(University of Freiburg), Andreas Burchert(University of Freiburg), Andreas Neubauer(Philipps University of Marburg), Dietrich W. Beelen(University of Freiburg), Andréas Mackensen(University of Freiburg), Nikolas von Bubnoff(University of Freiburg), Wolfgang Herr(University Hospital Regensburg), Burkhard Becher(University of Zurich), Gèrard Socié(Inserm), Michael A. Caligiuri(The Ohio State University), Eliana Ruggiero(Vita-Salute San Raffaele University), Chiara Bonini(Vita-Salute San Raffaele University), Georg Häcker(University of Freiburg), Justus Duyster(University of Freiburg), Jürgen Finke(University of Freiburg), Erika L. Pearce(Max Planck Institute of Immunobiology and Epigenetics), Bruce R. Blazar(University of Minnesota), Robert Zeiser(University of Freiburg)
Cited by 287Open Access